Antiretroviral therapy coverage among people living with hiv in Algeria
Algeria: Antiretroviral therapy coverage among people living with hiv was 68 in 2024. ◆ Volatile
Antiretroviral therapy coverage among people living with hiv in Algeria, 2000–2024
Source: Our World in Data.
Analysis
In 2024, antiretroviral therapy coverage among people living with hiv in Algeria stood at 68.
The figure is down 4.2% on the previous year and up 58.1% over ten years.
Over the whole period, antiretroviral therapy coverage among people living with hiv in Algeria peaked at 74 in 2021 and was at its lowest, 6, in 2000.
Algeria ranks 82nd of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage among people living with hiv in Algeria, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 6 | — |
| 2001 | 7 | +16.7% |
| 2002 | 8 | +14.3% |
| 2003 | 8 | +0.0% |
| 2004 | 9 | +12.5% |
| 2005 | 10 | +11.1% |
| 2006 | 13 | +30.0% |
| 2007 | 13 | +0.0% |
| 2008 | 13 | +0.0% |
| 2009 | 16 | +23.1% |
| 2010 | 21 | +31.2% |
| 2011 | 23 | +9.5% |
| 2012 | 28 | +21.7% |
| 2013 | 35 | +25.0% |
| 2014 | 43 | +22.9% |
| 2015 | 51 | +18.6% |
| 2016 | 59 | +15.7% |
| 2017 | 64 | +8.5% |
| 2018 | 69 | +7.8% |
| 2019 | 72 | +4.3% |
| 2020 | 72 | +0.0% |
| 2021 | 74 | +2.8% |
| 2022 | 69 | -6.8% |
| 2023 | 71 | +2.9% |
| 2024 | 68 | -4.2% |
Algeria compared with similar countries
- Algeria's 68 is above the median for upper middle income countries, which is 65.5, 1.0× the median. (40 countries reporting)
- Algeria's 68 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 59.5, 1.1× the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.3 | 6 | 16 | 10 |
| 2010s | 46.5 | 21 | 72 | 10 |
| 2020s | 70.8 | 68 | 74 | 5 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Un projection of annual infant deaths 1,455 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0485 units per person (2025)
Frequently asked questions
- What is antiretroviral therapy coverage among people living with hiv in Algeria?
- Antiretroviral therapy coverage among people living with hiv in Algeria was 68 in 2024, according to Our World in Data.
- What is the highest antiretroviral therapy coverage among people living with hiv recorded in Algeria?
- The highest recorded value was 74 in 2021.
- What is the lowest antiretroviral therapy coverage among people living with hiv recorded in Algeria?
- The lowest recorded value was 6 in 2000.
- How does Algeria rank for antiretroviral therapy coverage among people living with hiv?
- Algeria ranks 82nd out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage among people living with hiv rising or falling in Algeria?
- Over the last ten years it is up 58.1%. The long-run trend across the full record is volatile.
- Where does this Algeria data come from?
- The figures come from Our World in Data, published as part of Antiretroviral therapy coverage among people living with hiv. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).